×

Tissue shaping device

  • US 9,827,100 B2
  • Filed: 09/09/2016
  • Issued: 11/28/2017
  • Est. Priority Date: 01/30/2002
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of minimally-invasively treating mitral valve regurgitation, comprising:

  • advancing an intraluminal cardiac device in a collapsed configuration through a delivery device into a coronary sinus, the intraluminal cardiac device comprising a first expandable anchor, a second expandable anchor, and a connecting member extending between the first and second expandable anchors;

    expanding the first expandable anchor and anchoring the first expandable anchor against movement in the coronary sinus;

    expanding the second expandable anchor and anchoring the second expandable anchor against movement in the coronary sinus;

    after the first and second expandable anchors are anchored against movement, delivering a lead and an electrode of an electrophysiology system into the coronary sinus and through the first and second expandable anchors; and

    using the intraluminal cardiac device to change the geometry of the mitral valve annulus, bringing the leaflets of the mitral valve closer together, thereby reducing undesirable blood flow regurgitation of the mitral valve during the heart cycle.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×